Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses
Clinical trial NCT02045940 · COMPLETED
Trial details
- NCT number
- NCT02045940
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-20
- Primary completion
- 2015-03-26
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.